By proceeding, you agree to our Terms of Use and Privacy Policy.
Tillotts Pharma AG (“Tillotts”), part of the Japanese Zeria Group, is a fast-growing specialty pharma company with over 300 employees in Switzerland and abroad. Tillotts is dedicated to the development, in/out-licensing and commercialisation of innovative pharmaceutical products for the digestive system. Tillotts successfully markets its own products for the treatment of IBD as well as in-licensed products, in over 65 countries through its affiliates within Europe and a network of gastroenterology-focused partners throughout the world.
17-19 July 2023
Welcome to the Biotech CEO Summit 2023, an exclusive gathering designed specifically for CEOs in the biotechnology industry. This summit sets itself apart from other conferences by prioritizing the CEOs themselves and the unique challenges they face
Event Ended
USA
Paid
San Diego